
Core Laboratories Inc. (NYSE:CLB – Free Report) – Analysts at Zacks Research boosted their Q1 2027 earnings estimates for Core Laboratories in a report issued on Wednesday, February 25th. Zacks Research analyst Team now expects that the oil and gas company will earn $0.19 per share for the quarter, up from their prior forecast of $0.17. The consensus estimate for Core Laboratories’ current full-year earnings is $0.96 per share. Zacks Research also issued estimates for Core Laboratories’ Q2 2027 earnings at $0.38 EPS, Q3 2027 earnings at $0.33 EPS, Q4 2027 earnings at $0.38 EPS and FY2028 earnings at $1.74 EPS.
Separately, Weiss Ratings reiterated a “hold (c)” rating on shares of Core Laboratories in a research note on Monday, December 29th. Four analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $12.50.
Core Laboratories Trading Down 0.5%
Shares of NYSE:CLB opened at $17.43 on Thursday. The stock’s 50-day simple moving average is $18.31 and its two-hundred day simple moving average is $15.18. The stock has a market capitalization of $811.54 million, a price-to-earnings ratio of 26.01, a PEG ratio of 15.29 and a beta of 1.09. Core Laboratories has a 52-week low of $9.72 and a 52-week high of $20.36. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.57 and a current ratio of 2.07.
Core Laboratories (NYSE:CLB – Get Free Report) last released its quarterly earnings results on Wednesday, February 4th. The oil and gas company reported $0.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.20 by $0.01. The firm had revenue of $138.26 million for the quarter, compared to the consensus estimate of $130.40 million. Core Laboratories had a return on equity of 12.09% and a net margin of 6.04%.The company’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same period last year, the business posted $0.22 EPS. Core Laboratories has set its Q1 2026 guidance at 0.110-0.150 EPS.
Core Laboratories Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 9th. Stockholders of record on Monday, February 16th will be paid a $0.01 dividend. The ex-dividend date of this dividend is Friday, February 13th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. Core Laboratories’s dividend payout ratio is 5.97%.
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in CLB. Aster Capital Management DIFC Ltd bought a new stake in shares of Core Laboratories in the fourth quarter worth about $34,000. CWM LLC increased its stake in Core Laboratories by 36.1% in the 4th quarter. CWM LLC now owns 2,516 shares of the oil and gas company’s stock worth $40,000 after acquiring an additional 668 shares during the last quarter. Quarry LP lifted its position in Core Laboratories by 118.1% during the third quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock valued at $36,000 after purchasing an additional 1,599 shares during the last quarter. Hantz Financial Services Inc. increased its holdings in shares of Core Laboratories by 124.7% in the 4th quarter. Hantz Financial Services Inc. now owns 3,177 shares of the oil and gas company’s stock worth $51,000 after buying an additional 1,763 shares during the last quarter. Finally, GAMMA Investing LLC raised its position in shares of Core Laboratories by 73.3% during the 4th quarter. GAMMA Investing LLC now owns 5,157 shares of the oil and gas company’s stock valued at $83,000 after buying an additional 2,181 shares in the last quarter. Hedge funds and other institutional investors own 97.81% of the company’s stock.
Core Laboratories Company Profile
Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.
The company’s portfolio spans two primary service lines: reservoir description and production enhancement.
Read More
- Five stocks we like better than Core Laboratories
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
